The European Society of Clinical Microbiology and Infectious Diseases Improving the diagnosis, treatment and prevention of infection-related diseases
Basel
Joined January 2010
- Tweets18.1K
- Following3.8K
- Followers38.3K
- Likes6.8K
ESCMID retweeted
An original article on persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: clinicalmicrobiologyandinfec…
ESCMID retweeted
This systematic review and meta-analysis aims to evaluate whether infections caused by metallo-β-lactamase (MBL)- vs. serine β-lactamase (SBL)-producing Enterobacterales are associated with differences in mortality among hospitalized adults:
clinicalmicrobiologyandinfec…
ESCMID retweeted
This Narrative Review provides an overview of E-values and the bounding factor, a relatively new metric to assess robustness to unmeasured confounding:
clinicalmicrobiologyandinfec…
ESCMID retweeted
Original article investigating the bidirectional associations between bacteraemia and CMV infection and their impact on transplantation outcomes, as well as the effect of LTV prophylaxis on these associations: clinicalmicrobiologyandinfec…
ESCMID retweeted
Original article evaluating whether early antifungal prophylaxis reduces the incidence of influenza-associated pulmonary aspergillosis (IAPA) in critically ill adults with influenza: clinicalmicrobiologyandinfec…
ESCMID retweeted
📣 In the October 2026 issue:
The @ESCMID framework for reaching consensus in clinical guidelines
clinicalmicrobiologyandinfec…
ESCMID retweeted
In honor of #PeerReviewWeek we would like to thank our peer reviewers for their important and insightful contributions to CMI. We deeply value the time, effort and expertise that goes into writing each peer-review.
ESCMID retweeted
Development of new antifungal agents is challenging because of limited target sites, emergence of resistance, and adverse toxicity profiles. New agents offer alternative options for difficult-to-treat infections: clinicalmicrobiologyandinfec…
ESCMID retweeted
📣 In the September 2026 issue: Andes virus–associated cardiopulmonary syndrome: diagnostic approaches, clinical management, and evidence gaps—a scoping review
clinicalmicrobiologyandinfec…
ESCMID retweeted
Community-acquired pneumonia (CAP) is a leading cause of healthcare visits. This study aims to examine the effectiveness of doxycycline for outpatient CAP compared with other antibiotics:
clinicalmicrobiologyandinfec…
ESCMID retweeted
A systematic review and meta-analysis evaluating the impact of nudging in microbiology reports on antimicrobial use and clinical outcomes:
clinicalmicrobiologyandinfec…
ESCMID retweeted
Enterococcus faecalis is a challenging cause of endocarditis and often occurs in elderly, frail patients. The aim of this study was to evaluate the use of moxifloxacin for treating E. faecalis endocarditis: clinicalmicrobiologyandinfec…
ESCMID retweeted
This prospective, population-based study examines the incidence, clinical presentation, and prognosis of infectious encephalitis among adults in Denmark: clinicalmicrobiologyandinfec…
ESCMID retweeted
New original article demonstrates that DENOVA supports risk stratification for IE in patients with EfB, informing clinical decision-making and use of transoesophageal echocardiography.
Read the full article: clinicalmicrobiologyandinfec…
ESCMID retweeted
📣 New Supplement publication in CMI
The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the #EUCAST Subcommittee @ESCMID
Read here: clinicalmicrobiologyandinfec…
ESCMID retweeted
📣 Deadline for the open call to join the CMI editorial board as an editor in virology is July 31st!
Learn more about the qualifications and expectations of the role, and how to apply in the editorial note: ow.ly/iVSJ50YUtvb
ESCMID retweeted
🌟 The 2025 JCR Impact Factor for CMI has risen to 8.7!
We thank our editors, reviewers, authors and readers for their dedication and extraordinary work.
Read about how CMI did in 2025 here: clinicalmicrobiologyandinfec…
#IDTwitter #Microbiology #InfectiousDiseases #JIF #JCR2025
ESCMID retweeted
🚀 Help shape a new global community for early-career researchers in antimicrobial R&D.
#REVIVE by GARDP is exploring a global online community for networking, mentorship, collaboration, and career development—and we want your input.
If you're a student, PhD candidate, postdoc, clinician or early-career professional in antimicrobial R&D, please complete our 8–10 minute survey.
We also welcome responses from senior researchers to help shape mentorship and community priorities.
🔗 office.pulse.ly/xrwzthwcoo
Please share with colleagues and your networks. Your feedback will help shape a community built by and for early-career researchers!
